Boston Scientific (BSX) total debt

Total debt · fiscal 2025
$11.44B

Boston Scientific (BSX) carried total debt of $11.44B at the end of fiscal 2025 (December 31, 2025). That is 6.4% higher than the $10.75B of fiscal 2024. Figures as of 18 Nov 2026, 06:29 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total debt, fiscal 2025
$11.44B
Change on fiscal 2024
+6.4%
Growth, 10 years
+7.3% a year
Highest on record
$11.44Bfiscal 2025
Lowest on record
$4.20Bfiscal 2013
Fiscal years on record
122010–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Boston Scientific total debt, in more detail

Over the ten fiscal years to 2025 total debt grew at a compound 7.3% a year. Across the 12 fiscal years on record (2010–2025), the highest was $11.44B in fiscal 2025 and the lowest $4.20B in fiscal 2013.

Total debt was 0.5× shareholders' equity at the end of fiscal 2025.

History · 12 fiscal years

Total debt by fiscal year

Boston Scientific total debt, year by year

Boston Scientific (BSX) total debt by fiscal year
Fiscal yearTotal debtChangeYear endedDebt ÷ equity
2025$11.44B 6.4% up0.5×
2024$10.75B 13.2% up0.5×
2023$9.49B 2.3% up0.5×
2022$9.28B—0.5×
2017$5.62B 1.0% down0.8×
2016$5.67B 0.4% up0.8×
2015$5.65B 22.8% up0.9×
2014$4.60B 9.5% up0.7×
2013$4.20B 0.1% down0.6×
2012$4.20B 0.0%0.6×
2011$4.20B 29.4% down0.4×
2010$5.95B—0.5×

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

How to read it

Debt magnifies results in both directions — set it against cash, equity and the profit available to pay the interest rather than reading it alone.

Total debt at health care companies of similar size

Total debt of Boston Scientific and comparable companies
CompanyTotal debtFiscal year
Takeda Pharmaceutical TAK¥4.88T2026
Cencora COR$7.66B2025
Boston Scientific BSX$11.44B2025
Cardinal Health CAH$8.89B2026
argenx ARGX$47.16M2025
Edwards Lifesciences EW$705.40M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on BSX

Boston Scientific, figure by figure

Boston Scientific (BSX) overview: price, valuation and scorecardAll health care companies by market value

Boston Scientific total debt: questions and answers

How much debt does Boston Scientific have?

Boston Scientific (BSX) carried total debt of $11.44B at the end of fiscal 2025 (December 31, 2025). That is 6.4% higher than the $10.75B of fiscal 2024.

What is the growth rate of Boston Scientific's total debt?

Over the ten fiscal years to 2025 total debt grew at a compound 7.3% a year.

What are the highest and lowest total debt figures on record for Boston Scientific?

Across the 12 fiscal years on record (2010–2025), the highest was $11.44B in fiscal 2025 and the lowest $4.20B in fiscal 2013.

How does Boston Scientific's debt compare with its equity?

Total debt was 0.5× shareholders' equity at the end of fiscal 2025.

How is Boston Scientific's total debt calculated?

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Boston Scientific (BSX) total debt”, data as of 18 November 2026. https://funkfolio.com/stock/BSX/total-debt

Underlying data: the company's filings with the SEC and Yahoo Finance.